NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), clinical-stage biopharmaceutical company developing non-antibiotic, topical antimicrobial products, today reported first quarter 2014 financial results and provided an update on clinical progress.
Help employers find you! Check out all the jobs and post your resume.
